CBLL
CeriBell, Inc.
NASDAQ · USHealthcareMedical - Devices
$18.43-1.55%
Price as of Jul 20, 2026
CBLL growth
CeriBell, Inc. growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- +33.7%
- EBITDA
- -38.0%
- EBIT
- -42.8%
- EPS
- +38.7%
- Free cash flow
- -30.6%
- Operating cash flow
- -32.0%
Forward estimates
- Revenue
- +35.8%
- EBITDA
- -54.1%
- EPS
- +28.4%
Three-year CAGR
- Revenue
- +50.9%
- EBITDA
- -34.5%
- EBIT
- -47.1%
- Net income
- -32.0%
- EPS
- +56.9%
- Free cash flow
- -14.3%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.